NCT01486758View on ClinicalTrials.gov

Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
RSV Bronchiolitis
Interventions
DRUG

Azithromycin

Oral azithromycin 10 mg/kg once daily for 7 days followed by 5mg/kg once daily for additional 7 days.

DRUG

Placebo

Trial Locations (1)

63110

Department of Pediatrics, Washington University School of Medicine; and St. Louis Children's Hospital, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01486758 - Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis | Biotech Hunter | Biotech Hunter